Home ›
Entities
› academia
› Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
Research article (European Journal of Cancer, 2016) · cited 31× · AI/ML
Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
Summary
Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) is a scholarly article[1].
Key Facts
Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC). Retrieved May 24, 2026, from https://4ort.xyz/entity/initial-results-from-a-phase-1a-b-study-of-omp-131r10-a-first-in-class-anti-rspo3-antibody-in-advanced-solid-tumors-and-
MLA“Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC).” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/initial-results-from-a-phase-1a-b-study-of-omp-131r10-a-first-in-class-anti-rspo3-antibody-in-advanced-solid-tumors-and-.
BibTeX@misc{4ortxyz_initial-results-from-a-phase-1a-b-study-of-omp-131r10-a-first-in-class-anti-rspo3-antibody-in-advanced-solid-tumors-and-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)}}, year = {2026}, url = {https://4ort.xyz/entity/initial-results-from-a-phase-1a-b-study-of-omp-131r10-a-first-in-class-anti-rspo3-antibody-in-advanced-solid-tumors-and-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) — https://4ort.xyz/entity/initial-results-from-a-phase-1a-b-study-of-omp-131r10-a-first-in-class-anti-rspo3-antibody-in-advanced-solid-tumors-and- (retrieved 2026-05-24)
